SCHEMBL30575992

SCHEMBL30575992

Nc1nc(N2CCNCC2)nc2ccccc12

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.70
KDM4E B2RXH2 7/20 0.70
HPGD P15428 5/20 0.70
GLA P06280 3/20 0.70
GAA P10253 3/20 0.70
HSD17B10 Q99714 2/20 0.70
HTR3A P46098 1/20 0.70
HRH4 Q9H3N8 1/20 0.70
ALOX15 P16050 1/20 0.70
HTT P42858 1/20 0.70
RAB9A P51151 2/20 0.60
NPC1 O15118 1/20 0.60
HK1 P19367 1/20 0.60
HKDC1 Q2TB90 1/20 0.60
TSHR P16473 2/20 0.59
NCF1 P14598 3/20 0.58
APAF1 O14727 1/20 0.57
POLB P06746 1/20 0.57
MAPT P10636 1/20 0.57
UBE2N P61088 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11817813 1.00 ALDH1A1 (0.70) ALDH1A1KDM4EHPGDGLAGAA
Hydrochloric Acid SCHEMBL30576212 0.98 ALDH1A1 (0.73) ALDH1A1KDM4EHPGDGLAGAA
SCHEMBL742359 0.85 KDM4E (0.94) ALDH1A1KDM4EHPGDGLAGAA
SCHEMBL30547000 0.85 KDM4E (0.94) ALDH1A1KDM4EHPGDGLAGAA
SCHEMBL3641196 0.84 KDM4E (0.97) ALDH1A1KDM4EHPGDGLAGAA
SCHEMBL11741104 0.83 HRH4 (1.00) ALDH1A1KDM4EHPGDGLAGAA
SCHEMBL30513776 0.83 HRH4 (1.00) ALDH1A1KDM4EHPGDGLAGAA
SCHEMBL11739391 0.81 KDM4E (1.00) ALDH1A1KDM4EHPGDGLAGAA
SCHEMBL1083762 0.81 RAB9A (0.77) ALDH1A1KDM4EHPGDGLAGAA
Hydrochloric Acid SCHEMBL11738196 0.81 HRH4 (0.97) ALDH1A1KDM4EHPGDGLAGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4476211-A1 ACYLATED HETEROCYCLIC QUINAZOLINE DERIVATIVES AS INHIBITORS OF ERBB2 Enliven Inc. (US) 2024-12-18 EP disclosed
WO-2023154124-A1 ACYLATED HETEROCYCLIC QUINAZOLINE DERIVATIVES AS INHIBITORS OF ERBB2 ENLIVEN THERAPEUTICS, INC. (US) 2023-08-17 WO disclosed